Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 1 × Has announcements × 30 days × Clear all

Phase

Phase 3 27 Phase 2 14 Phase 1/2 11 Phase 1 2

Status

Active not recruiting 2

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1 Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

talquetamab 1 lazertinib 1 amivantamab 1 Pemetrexed 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02609776 2026-04-13

CHRYSALIS

Janssen Research & Development, LLC

Phase 1 Active not recruiting

751 enrolled 2 FDA

Carcinoma, Non-Small-Cell Lung

NCT03399799 2026-04-13

MonumenTAL-1

Janssen Research & Development, LLC

Phase 1 Active not recruiting

279 enrolled 2 FDA

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡